Last reviewed · How we verify
Targeted Systemic Therapy — Competitive Intelligence Brief
phase 3
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Targeted Systemic Therapy (Targeted Systemic Therapy) — Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Targeted Systemic Therapy is a cancer treatment designed to selectively target and destroy malignant cells while minimizing damage to healthy tissue.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Targeted Systemic Therapy TARGET | Targeted Systemic Therapy | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Targeted Systemic Therapy CI watch — RSS
- Targeted Systemic Therapy CI watch — Atom
- Targeted Systemic Therapy CI watch — JSON
- Targeted Systemic Therapy alone — RSS
Cite this brief
Drug Landscape (2026). Targeted Systemic Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/targeted-systemic-therapy. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab